Journal of cardiac failure
2023 Update of the Japanese Heart Failure Society Scientific Statement on BNP and NT-proBNP Levels in Heart Failure Practice
Abstract
This revised 2023 statement on blood brain (B-type) natriuretic peptide (BNP) and N-terminal prohormone of brain (B-type) natriuretic peptide (NT-proBNP) represents an expert consensus that aims to enhance efficient referral from general practitioners or non-cardiovascular specialists, providing a comprehensive, up-to-date perspective on BNP and NT-proBNP in the diagnosis and management of heart failure, with a focus on the following two major modifications: (1) Changes regarding cutoff values for BNP and NT-proBNP (criteria for heart failure diagnosis and referral criteria to cardiovascular specialists); and (2) Content related to heart failure management using BNP and NT-proBNP (BNP-guided therapy).
Source and rights
Published by Journal of cardiac failure, 2025. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Published
- 2025
- Applies to
- 🇪🇺 Europe
- Scope
- Regional
- Journal
- Journal of cardiac failure
- PubMed
- 40120714
- Added to Prognia
More in cardiology
- HRS position statement: Changing the tide in CPR and AED education for students in the United StatesHeart Rhythm Society · 2026
- Summary of the International Society for Heart and Lung Transplantation (ISHLT) Consensus Conference on Graft Dysfunction within the First 72 hours after Heart Transplantation: A 10-year UpdateThe International Society for Heart and Lung Transplantation (ISHLT) [1, 2] · 2026
